Integrating Genomic Medicine into Public Health: A Comprehensive Review of Advancements, Challenges, and Ethical Considerations

Abstract

This review explores the integration of genomic medicine into public health, with a focus on advancements, challenges, and ethical considerations. The objectives included understanding disease predisposition, enhancing diagnostics, and optimizing treatment plans to improve population health outcomes. This review evaluates current literature, case studies, and ongoing public health genomics initiatives, such as the Genomic England 100,000 Genomes Project, to assess successful integration strategies and identify barriers to implementation. Genomic advancements, such as precision medicine, demonstrate considerable potential in personalised healthcare. However, challenges remain, particularly concerning accessibility, high costs, and ethical issues like privacy, informed consent, and genetic discrimination. Addressing these issues requires the development of comprehensive governance frameworks. The successful integration of genomics into public health will depend on interdisciplinary collaboration, investments in education, equitable access, and ongoing research. Ethical governance frameworks and active community engagement are essential for ensuring responsible genomic integration and achieving positive health outcomes.

References

1. 1.Abul-Husn NS, Soper ER, Braganza GT, et al. Implementing genomic screening in diverse populations. Genome Med. 2021;13:17. https://doi. org/10.1186/s13073-021-00832-y. doi:10.1186/s13073-021-00832-y
2. 2.Arredondo-Alonso S, Top J, Corander J, Willems RJL, Schürch AC. Mode and dynamics of vanA-type vancomycin resistance dissemination in Dutch hospitals. Genome Med. 2021;13(1):9. https://doi.org/10.1186/s13073-020- 00825-3. doi:10.1186/s13073-020-
3. 3.Aschenbrenner AC, Mouktaroudi M, Krämer B, et al. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.Genome Med. 2021;13(1):7. https://doi.org/10.1186/s13073-020- 00823-5. doi:10.1186/s13073-020-
4. 4.AssociationofSchoolsandProgramsof Public Health. Areas of Study.https:// www.aspph.org/study/#areas-of-study. 112 Majmaah Journal of Health Sciences ,Vol.13, Issue1 , January-2025,Rajab -1446 Integrating Genomic Medicine into Public Health:AComprehensiveReviewofAdvancements,Challenges,andEthicalConsiderations Published 2020.
5. 5.Baker DJ, Aydin A, Le-Viet T, et al. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes. Genome Med. 2021;13(1):21. https:// doi.org/10.1186/s13073-021-00839- doi:10.1186/s13073-021-00839-
6. 6.Berbel Caban A, Pak TR, Obla A, Dupper AC, Chacko KI, Fox L, et al. PathoSPOTgenomicepidemiologyreveals under-the-radar nosocomial outbreaks. Genome Med. 2020;12(1):96. https://doi.org/10.1186/s13073-020- 00798-3. doi:10.1186/s13073-020-
7. 7.Burton H,Cole T,Farndon P.Genomics in Medicine: Delivering genomics through clinical practice.Report on the Joint Committee on Medical Genetics. London: PHG Foundation,2012.
8. 8.Burton H, Cole T, Lucassen AM. Genomic medicine: challenges and opportunities for physicians. Clin Med (Lond). 2012 Oct;12(5):416-9. doi: 10.7861/clinmedicine.12-5-416. Erratumin:ClinMed.2012Dec;12(6):504. PMID: 23101139; PMCID: PMC4953761. doi:10.7861/clinmedicine.12-5-416